Skip to main content

Chemotherapy of babesiosis

  • Chapter
Malaria and Babesiosis

Part of the book series: New Perspectives in Clinical Microbiology ((NPCM,volume 7))

Abstract

Babesiosis (Texas fever, redwater, tick fever, etc.) was first described in 1893 by Smith and Kilborne as a tick-transmitted disease of cattle, characterized by anemia, fever, and hemoglobinuria [1]. Since then, however, it has been found that most domestic and many wild mammals are susceptible to a wide variety of Babesia species [2]. These babesias tend to be host-specific, but this is not always the case. Generally, however, the disease in a given mammalian host, referred to as babesiosis, is caused by a specific Babesia species. A list of different babesias and their major vertebrate hosts, as discussed in this review, is given in table 1. With the ever broadening scope of babesiosis in man and animal, increasing attention is being given to the development of appropriate treatment to moderate clinical signs in acutely infected individuals, to eliminate, and to prevent infection.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Smith T, Kilbourne FL: Investigations into the nature, causation and prevention of Texas or Southern cattle fever. US Dept Agriculture, Bureau of Animal Industry, Bull. No. 1, 1–301, 1893.

    Google Scholar 

  2. Purnell RE: Babesiosis in various hosts. In Babesiosis, pp. 25–63. Ristic M, Kreier JP, eds. New York: Academic Press, 1981.

    Google Scholar 

  3. Bredt AB, Weinstein WM, Cohen S: Treatment of babesiosis in asplenic patients. J Am of Med Assoc 245:1938–1939, 1981.

    Article  CAS  Google Scholar 

  4. Brocklesby DW: Human babesiosis. J S Afr Vet Assoc 50:302–307,1979.

    PubMed  CAS  Google Scholar 

  5. Skrabalo Z, Deonovic Z: Piroplasmosis in man. Report on a case. Doc Med Georgr et Trop 9:11–16, 1957.

    CAS  Google Scholar 

  6. Zaino EC, Amelkin S: Babesiosis: A potentially grave disease for the immunosuppressed. N Y State J Med 81:384, 1981.

    PubMed  CAS  Google Scholar 

  7. Filstein MR, Benach JL, White DJ, Brody BA, Goldman WD, Bakal CW, Schwartz RS: Serosurvey for human babesiosis in New York. J Infect Dis 141:518–521,1980.

    Article  PubMed  CAS  Google Scholar 

  8. Anderson JF, Magnarelli LA: Canine Babesia, new to North America. Science 204:1431–1432, 1979.

    Article  PubMed  CAS  Google Scholar 

  9. Vercruysse J, Parent R: Report of an account of porcine babesiosis due to Babesiaperroncitoi in Senegal. Afrique Medicale 20 (192):435–437, 1981.

    Google Scholar 

  10. Potgieter FT: Chemotherapy of Babesia felis infection: Efficacy of certain drugs. J S Afr VetAssoc 52:289–293, 1981

    CAS  Google Scholar 

  11. Kuttler KL: Chemotherapy of babesiosis: A review. In Babesiosis, pp. 65–85. Ristic M, Kreier JP, eds. New York: Academic Press, 1981.

    Google Scholar 

  12. DeVos AJ: Epidemiology and control of bovine babesiosis in South Africa. J S Afr Vet Assoc 50:357–362, 1979.

    CAS  Google Scholar 

  13. Lewis D, Purnell RE, Francis MA, Young ER: The effect of treatment with imidocarb diproprionate on the course of Babesia divergens infections in splenectomized calves and on their subsequent immunity to homologous challenge. J Comp Path 91:285–292, 1981.

    Article  PubMed  CAS  Google Scholar 

  14. Beveridge E:Babesia rodhaini: A useful organism for the testing of drugs designed for the treatment of piroplasmosis. Ann Trop Med Parasit 47:134, 1953.

    PubMed  CAS  Google Scholar 

  15. Lucas JMS: The chemotherapy of experimental babesiasis in mice and splenectomized calves. Res Vet Sci 1:218–225, 1960.

    CAS  Google Scholar 

  16. Lewis D, Williams H: Infection of the Mongolian gerbil with the cattle piroplasm, Babesia divergens. Nature 278:170. 1979.

    Article  PubMed  CAS  Google Scholar 

  17. Irvin AD, Young ER: Possible in vitro test for screening drugs for activity against Babesia and other blood protozoa. Nature 169:407–409, 1977.

    Article  Google Scholar 

  18. Irvin AD, Young ER: Further studies on the uptake of tritiated nucleic acid precursors by Babesia spp. of cattle and mice. Int J Parasitol 9:109–114, 1979.

    Article  CAS  Google Scholar 

  19. Erp EE, Gravely SM, Smith RD, Ristic M, Osorno BM, Carson CA: Growth of Babesia bovis in bovine erythrocyte cultures. Am J Trop Med Hyg 27:1061–1064, 1978.

    PubMed  CAS  Google Scholar 

  20. Levy MG, Ristic M: Continuous cultivation in a microaerophilous stationary phase culture. Science 207:1218–1220, 1980.

    Article  PubMed  CAS  Google Scholar 

  21. Newton BA: Interaction of berenil with deoxyribonucleic acid and some characteristics of the berenil-deoxyribonucleic acid complex. Biochem J 105:50–51, 1967.

    Google Scholar 

  22. Neville DM: The interaction of acridine dyes with DNA. An x-ray diffraction and optical investigation. J Molec Biol 17:57–74, 1966.

    Article  PubMed  CAS  Google Scholar 

  23. Hebel R, Dennig HK: Licht und Elektronenmikroskopische Untersuchungen an Babesia her- pailuri nach Behandlung mit 4,4‘Diamidinodiazoamino-benzol’ (Berenil). Z Parasitenkd 33:1– 20,1969.

    Article  PubMed  CAS  Google Scholar 

  24. Simpson CF, Neal FC: Ultrastructure ofBabesia equi in ponies treated with imidocarb. Am J Vet Res 41:267–271, 1980.

    PubMed  CAS  Google Scholar 

  25. Göbel E, Dennig HK: Die Ultrastruktur der Trophozoiten und Merozoiten von Babesia herpailuri in Erythrozyten der Hauskatze nach Behandlung mit Imidocarb (3,3-bis- 2-imidazolin-2-yl)-carbanilid. Z Parasitenkd 49:97–112,1976.

    Article  PubMed  Google Scholar 

  26. Joyner LP: The chemotherapy of protozoal infections of veterinary importance. J Protozool 28:17–19, 1981.

    PubMed  CAS  Google Scholar 

  27. Dalgliesh RJ, Stewart NP: Tolerance to imidocarb induced experimentally in tick-transmitted Babesia argentina. Austr Vet J 53:176–180, 1977.

    Article  CAS  Google Scholar 

  28. Theiler A: The treatment of Redwater in cattle with trypan blue. Vet J 68:64–73,1912.

    Google Scholar 

  29. Rees CW: Characteristics of the piroplasms Babesia argentina and Babesia bigemina in the United States. J Agric Res 48(5):427–438, 1934.

    Google Scholar 

  30. Legg J: The treatment of piroplasmosis (P. bigeminum) with akiron. Aust Vet J 12:227–230, 1936.

    Article  Google Scholar 

  31. Legg J: The treatment of babesiellosis (B. argentina) with acaprin. Aust Vet J 15:121–123,1939.

    Article  CAS  Google Scholar 

  32. Lohr FK, Otieno PS, Gacanga W: Therapy trial using betamethasone in addition to specific treatment with a diamidine and quinuronium derivate in cattle experimentally infected with Babesia bigemina. Bull Anim Hlth Prod XXIV, 199–205, 1976.

    Google Scholar 

  33. Vanzini VR, Gomez MR, Hadani A, Bermudez AC, Luciani CA, Guglielmone AA, Angold AJ: A case of intestinal torsion in a cow, apparently caused by administration of acaprin as a babesiacide. Rev Med Vet Argentina 6:503–506, 1981.

    Google Scholar 

  34. Eyre P: Some pharmacodynamic effects of the babesicidal agents quinuronium and amicar- balide. J Pharm Pharmacol 19:509–519, 1967.

    Article  PubMed  CAS  Google Scholar 

  35. Barnett SF: The chemotherapy ofBabesia bigemina infection in cattle. Res Vet Sci 6:397–415, 1965.

    PubMed  CAS  Google Scholar 

  36. Purneil RE, Lewis D, Young ER: Quinuronium sulphate for the treatment of Babesia divergens infections of splenectomized calves. Vet Ree 108:538–539, 1981.

    Article  Google Scholar 

  37. Newton LG, O’Sullivan PJ: Chemoprophylaxis in Babesia argentina infection in cattle. Aust Vet j 45:404–407, 1969.

    Article  PubMed  CAS  Google Scholar 

  38. Ryley JF: A chemoprophylactic approach to babesiasis. Res Vet Sci 5:411–418,1964.

    Google Scholar 

  39. Riek RF: Babesiosis. In Infectious Blood Diseases of Man and Animals, pp. 219–268. Weinman D, Ristic M, eds. New York: Academic Press, 1968.

    Google Scholar 

  40. Adam KMG, Blewett DA, Collins TJ, Edgar JT: Outbreaks of babesiasis on two farms in Scotland. Br Vet J 134:428–433, 1978.

    PubMed  CAS  Google Scholar 

  41. Pipano E, Weisman Y, Raz A, Klinger I: Immunity toBabesia bigemina in calves after successful babesicidal treatment of a previous infection. Refuah Vet 29:1–8,1972.

    Google Scholar 

  42. Collins JD, Nuallain TO, Ferguson AR: Observations on bovine babesiosis in Ireland. Irish Vet J 24:42–51, 1970.

    Google Scholar 

  43. Pipano E, Jeruhan I, Frank M: Pentamidine in chemoimmunisation of cattle against Babesia bigemina infections. Trop Anim Hlth Prod 11:13–16, 1979.

    Article  CAS  Google Scholar 

  44. Thompson KC, Todorovic RA, Mateus C, Adams LG: Methods to improve the health of cattle in the tropics: immunisation and chemoprophylaxis against haemoparasitic infections. Trop Anim Hlth Prod 10:75–81, 1978.

    Article  CAS  Google Scholar 

  45. Minami T, Ishihara T:Babesia ovata sp.n. isolated from cattle in Japan. Nat I Anim Hlth O (Jpn) 20:101–113, 1980.

    CAS  Google Scholar 

  46. Todorovic RA, Vizcaino OG, Gonzalez EF, Adams LG: Chemoprophylaxis (Imidocarb)againstBabesia bigemina and Babesia argentina infections. Am J Vet Res 34:1153–1161,1973.

    PubMed  CAS  Google Scholar 

  47. Callow LL, McGregor W: The effect of imidocarb against Babesia argentina and Babesia bigemina infections of cattle. Aust Vet J 46:195–200,1970.

    Article  PubMed  CAS  Google Scholar 

  48. Purnell RE, Rae MC, Deuk SM: Efficacy of imidocarb dipropionate and primaquine phosphate in the prevention of tickborne disease in imported Hereford heifers from South Korea. Trop Anim Hlth Prod 13:123–127,1981.

    Article  CAS  Google Scholar 

  49. Taylor RJ, McHardy N: Preliminary observations on the combined use of imidocarb and Babesia blood vaccine in cattle. J S Afr Vet Assoc 50:326–329,1979.

    PubMed  CAS  Google Scholar 

  50. Purnell RE, Lewis D, Young ER: Investigations on the prophylactic effect of treatment with imidocarb diproprionate on Babesia divergens infections in splenectomized calves. Brit Vet J 136:452–456, 1980.

    CAS  Google Scholar 

  51. Euzeby J, Rancien P, Simon PH: Outbreak of Babesia infection in the Charolles region of France. 3. Chemoprophylaxis by imidocarb. B Soc Sci Vet Med Comp de Lyon 76(6):423–426, 1974.

    Google Scholar 

  52. Haigh AJB, Hagan DH: Evaluation of imidocarb dihydrochloride against redwater disease in cattle in Eire. Vet Ree 94:56–69,1974.

    Article  CAS  Google Scholar 

  53. Kuttler KL, Graham OH, Trevino JL: The effect of imidocarb treatment on Babesia in the bovine and the tick (Boophilus microplus). Res Vet Sci 18:198–200,1975.

    PubMed  CAS  Google Scholar 

  54. Gray JS, Potgieter FT: The retention ofBabesia bigemina infection by Boophilus decoloratus exposed to imidocarb dipropionate during engorgement. Onderst J Vet Res 48:225–227,1981.

    CAS  Google Scholar 

  55. Mahoney DF, Mirre GB: A note on the transmission of Babesia bovis (syn. B. argentina) by the one host tick, Boophilus microplus. Res Vet Sci 26:253–254,1979.

    PubMed  CAS  Google Scholar 

  56. Potgieter FT: The life cycle of Babesia bovis and Babesia bigemina in ticks and in cattle in South Africa. Ph.D. Thesis, Rand Afrikaans University, Johannesburg, S. Africa, 1977.

    Google Scholar 

  57. Day WC, Kuttler KL: Animal health considerations involved in the movement of US cattle to Haiti. SW Vet 28:229–232, 1975.

    Google Scholar 

  58. DeLoach JR, Wagner GG, Craig TM: Imidocarb dipropionate encapsulation and binding to reseal carrier bovine erythrocytes for potential babesiosis chemotherapy. J Appl Biochem 3:254–262,1981.

    CAS  Google Scholar 

  59. Kuttler KL: Use of imidocarb to control anaplasmosis. SW Vet 28:47–52,1975.

    Google Scholar 

  60. Adams LG, Corrier DE, Williams JD: A study of the toxicity of imidocarb dipropionate in cattle. Res Vet Sci 28:172–177,1980.

    PubMed  CAS  Google Scholar 

  61. Aliu YO: Absorption, distribution, and excretion of imidocarb dipropionate (3,3’-bis- (2-imidazolin-2-yl)carbanilide) in sheep. Ph.D. dissertation. Texas A&M University, College of Veterinary Medicine, College Station, Texas, 1974.

    Google Scholar 

  62. Aliu YO, Davis RH, Camp B J, Kuttler KL: Absorption, distribution and excretion of imidocarb dipropionate in sheep. Am J Vet Res 38:2001–2006,1977.

    PubMed  CAS  Google Scholar 

  63. Wood JC: The activity of imidocarb against Babesia infections of cattle. Irish Vet J 25:254–257, 1971.

    Google Scholar 

  64. O’Neill AR: Blood transfusions in cattle with particular reference to ‘Redwater’ (Babesiosis). Irish Vet J 33:1–7, 1979.

    Google Scholar 

  65. DeKock GDW: Drug treatment inNuttalliosis. Union of S.A., Dept of Agric 7th and 8th Reports, Dir Vet Res 639–675, April 1918.

    Google Scholar 

  66. Malhotra DV, Gautam OP, Banerjee DP: A note on chemotherapeutic trials against Babesia equi infection in donkeys. I J Anim Sc 49:75–77, 1979.

    CAS  Google Scholar 

  67. Singh B, Banerjee DP, Gautam OP: Comparative efficacy of diminazine diaceturate and imidocarb dipropionate against B. equi infections in donkeys. Vet Parasit 7:173–179,1980.

    Article  CAS  Google Scholar 

  68. Frerichs WM, Holbrook AA: Treatment of equine piroplasmosis (B. caballi) with imidocarb dipropionate. Vet Ree 95:188–189, 1974.

    Article  CAS  Google Scholar 

  69. Kirkham WW: The treatment of equine babesiosis. J Am Vet Med Assoc 155:457–460,1969.

    PubMed  CAS  Google Scholar 

  70. Frerichs WM, Allen PC, Holbrook AA: Equine piroplasmosis (Babesia equi): Therapeutictrials of imidocarb dihydrochloride in horses and donkeys. Vet Ree 93:73–75,1973.

    Article  CAS  Google Scholar 

  71. Adams LG: Clinicopathological aspects of imidocarb dipropionate toxicity in horses. Res Vet Sci 31:54–61, 1981.

    PubMed  CAS  Google Scholar 

  72. Jansen BC: The parasiticidal effect of Aureomycin (Lederle) on Babesia equi (La Veran 1899) in splenectomized donkeys. Onderst J Vet Res 26:175–182,1953.

    CAS  Google Scholar 

  73. Dennig Von HK, Centurier C, Göbel E, Weiland G: Ein Beitrag zur Babesiose des Hundes und ihrer Bedeutung in der Bundesrepublik Deutschland und Berlin-West. Berl Münch Tierärztl Wschr 93:373–379,1980.

    CAS  Google Scholar 

  74. Moore DJ: Therapeutic implications of Babesia canis infection in dogs. J S Afr Vet Assoc 50:346–352, 1979.

    PubMed  CAS  Google Scholar 

  75. Button C: Metabolic and electrolyte disturbances in acute canine babesiosis. J Am Vet Med Assoc 175:475–479, 1979.

    PubMed  CAS  Google Scholar 

  76. Nuttall GHF, Hadwen S: The successful drug treatment of canine piroplasmosis, together with observations upon the effect of drugs onPiroplasma canis. Parasitol 2:156–191,1909.

    Article  Google Scholar 

  77. Groves MG, Dennis GL: Babesia gibsoni: Field and laboratory studies of canine infections. Exp Parasit 31:153–159,1972.

    Article  PubMed  CAS  Google Scholar 

  78. Groves MG, Vanniasingham JA: Treatment of Babesia gibsoni infections with phenamidine isethionate. Vet Ree 86:8–10,1970.

    Article  CAS  Google Scholar 

  79. Ruff MD, Fowler JL, Fernau RC, Matsuda K: Action of certain antiprotozoal compounds against Babesia gibsoni in dogs. Am J Vet Res 34:641–645,1973.

    PubMed  CAS  Google Scholar 

  80. Joyner LP, Davies SFM, Kendall SB: Chemotherapy of babesiosis. In Experimental Chemotherapy, Vol. I, pp. 603–624. Schnitzer RJ, Hawking F, eds. New York, Academic Press, 1963.

    Google Scholar 

  81. Klinefelter MR: Cause, diagnosis, and treatment of canine piroplasmosis. Vet Med/SAC 77:1505–1508, 1982.

    Google Scholar 

  82. Farwell GE, LeGrand EK, Cobb CC: Clinical observations on Babesia gibsoni and Babesia canis infections in dogs. J Am Vet Med Assoc 180:507–511,1982.

    PubMed  CAS  Google Scholar 

  83. Breitschwerdt EB, Malone JB, MacWilliams P, Levy MG, Quails CW, Prudish MJ: Babesiosis in the greyhound. J Am Vet Med Assoc 182:978–982,1983.

    PubMed  CAS  Google Scholar 

  84. Fowler JL, Ruff MD, Fernau RC, Furusho Y: Babesia gibsoni: Chemotherapy in dogs. Am J Vet Res 33:1109–1114, 1972.

    PubMed  CAS  Google Scholar 

  85. Stewart CG: A comparison of the efficacy of isometamidium, amicarbalide, and diminazene against Babesia canis in dogs and the effect on subsequent immunity. J S Afr Vet Assoc 54:47–51, 1983.

    PubMed  CAS  Google Scholar 

  86. Ogunkoya AB, Adeyanju JB, Aliu YO: Experiences with the use of imizol in treating canine blood parasites in Nigeria. J Sm Anim P 22:775–777,1981.

    Article  CAS  Google Scholar 

  87. Uilenberg G, Verdiesen PA, Zwart D: Imidocarb: A chemoprophylactic experiment with Babesia canis. Tijdschr. Diergeneesk 106:118–123, 1981.

    Google Scholar 

  88. Euzeby J, Moreau Y, Chauve C, Gevrey J, Gauthey M: Experimentation des propriétés antipiroplasmiques de l’Imidocarb sur Babesia canis, agent de la piroplasmose canine en Europe. B Aca Vet de France 53:475–480, 1980.

    Google Scholar 

  89. Coll JL, Descamps H, Fayette JP, Feraud JP, Villemin P: Essai de chimo-prevention de la Babesiose canine avec l’imidocarbe. Ree Med Vet 158:791–798,1982.

    Google Scholar 

  90. Futter GJ, Belonje PC: Studies on feline babesiosis. I. Historical Review. J S Afr Vet Assoc 50:105–106, 1980.

    Google Scholar 

  91. Stewart CG, Hackett KJW, Collett MG: An unidentified Babesia of the domestic cat (Felis domesticus). J S Afr Vet Assoc 51:219–221,1980.

    PubMed  CAS  Google Scholar 

  92. Ruebush TKII, Rubin RH, Wolpow ER, Cassaday PB, Schultz MG: Neurologic complications following the treatment of human Babesia microti infection with diminazene aceturate. Am J Trop Med Hyg 28:184–189, 1979.

    PubMed  Google Scholar 

  93. Entrican JH, Williams H, Cook IA, Lancaster WM, Clark JC, Joyner LP, Lewis D: Babesiosis in man: Report of a case from Scotland with observations on the infecting strain. J Infection 1:227–234,1979.

    Article  Google Scholar 

  94. Francioli PB, Keithly JS, Jones TC, Brandstetter RD, Wolf DJ: Response of babesiosis to pentamidine therapy. Ann Int Med 94:326–330,1981.

    PubMed  CAS  Google Scholar 

  95. Rowin KS, Tanowitz HB, Wittner M: Therapy of experimental babesiosis. Ann Int Med 97:556–558,1982.

    PubMed  CAS  Google Scholar 

  96. Wittner M, Rowin KS, Tanowitz HB, Hobbs JF, Saltzman S, Wenz B, Hirsch R, Chisholm E, Healy GR: Successful chemotherapy of transfusion babesiosis. Ann Int Med 96:601–604,1982.

    PubMed  CAS  Google Scholar 

  97. Gombert ME, Goldstein EJC, Benach JL, Tenebaum MJ, Grunwaldt E, Kaplan MH, Eveland LK: Human babesiosis, clinical and therapeutic considerations. JAMA 248:3005–3007,1982.

    Article  PubMed  CAS  Google Scholar 

  98. Michael SA, Refaii AH: The effect of imidocarb dipropionate on Babesia ovis infection in sheep. Trop Anim Hlth Prod 14:1–2, 1982.

    Article  CAS  Google Scholar 

  99. Hashemi-Fesharki R: Studies on imidocarb dihydrochloride in experimental Babesia ovis infection in splenectomized lambs. Br Vet J 133:609–614,1977.

    PubMed  CAS  Google Scholar 

  100. Lewis D, Herbert I: A large Babesia of sheep from north Wales. Vet Ree 107:352–353,1980.

    Article  CAS  Google Scholar 

  101. Uilenberg G, Rombach MC, Perie NM, Zwart D: Blood parasites of sheep in the Netherlands. II. Babesia motasi (Sporozoa babesiidae). Vet Q 2: 3–14, 1980.

    Google Scholar 

  102. Friedhoff KT: The piroplasms of equidae-significance for international commerce. Berl Münch Tierärztl Wschr 95:368–374. 1982.

    CAS  Google Scholar 

  103. Schein E, Rehbein G, Voigt WP, Zweygarth E: Babesia equi (Laveran 1901) 1. Development in horses and in lymphocyte culture. Tropenmed P 32:223–227,1981

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Martinus Nijhoff Publishers, Dordrecht

About this chapter

Cite this chapter

Kuttler, K.L., Aliu, Y.O. (1984). Chemotherapy of babesiosis. In: Ristic, M., Ambroise-Thomas, P., Kreier, J. (eds) Malaria and Babesiosis. New Perspectives in Clinical Microbiology, vol 7. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-6042-8_11

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-6042-8_11

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-009-6044-2

  • Online ISBN: 978-94-009-6042-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics